Mirion Technologies, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Millions	Total	Conversion of shares of class B common stock to class A common stock	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class A Common Stock Conversion of shares of class B common stock to class A common stock	Common Stock Class B Common Stock	Common Stock Class B Common Stock Conversion of shares of class B common stock to class A common stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital Conversion of shares of class B common stock to class A common stock	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Noncontrolling Interests	Noncontrolling Interests Conversion of shares of class B common stock to class A common stock
Beginning balance (in shares) at Oct. 19, 2021			9,976,164
Ending balance (in shares) at Oct. 20, 2021			18,750,000	18,750,000
Beginning balance (in shares) at Dec. 31, 2022					200,298,834		8,040,540
Beginning balance at Dec. 31, 2022	$ 1,467.2				$ 0.0		$ 0.0		$ 0.0	$ 1,882.4		$ (408.5)	$ (75.7)	$ 69.0
Beginning balance (in shares) at Dec. 31, 2022									0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued, conversion of convertible securities (in shares)					100	193,207		(193,207)
Stock issued for vested restricted stock units (in shares)					40,764
Stock compensation to directors in lieu of cash compensation (in shares)					12,090
Stock compensation to directors in lieu of cash compensation	0.1									0.1
Conversion of shares of class B common stock to class A common stock		$ 0.0									$ 1.6				$ (1.6)
Issuance of shares of class A common stock, net of offering costs (in shares)					17,142,857
Issuance of shares of class A common stock, net of offering costs	149.8									149.8
Stock-based compensation expense	5.5									5.5
Net loss	(42.9)											(41.9)		(1.0)
Other comprehensive income	8.3												8.0	0.3
Ending balance (in shares) at Mar. 31, 2023					217,687,852		7,847,333
Ending balance at Mar. 31, 2023	1,588.0				$ 0.0		$ 0.0		$ 0.0	2,039.4		(450.4)	(67.7)	66.7
Ending balance (in shares) at Mar. 31, 2023									0
Beginning balance (in shares) at Dec. 31, 2023			218,177,832	7,787,333	218,177,832		7,787,333
Beginning balance at Dec. 31, 2023	$ 1,550.0				$ 0.0		$ 0.0		$ (1.3)	2,056.5		(505.4)	(65.3)	65.5
Beginning balance (in shares) at Dec. 31, 2023	149,076								149,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued, conversion of convertible securities (in shares)						460,910		(460,910)
Stock issued for vested restricted stock units (in shares)					88,171
Stock compensation to directors in lieu of cash compensation (in shares)					8,420
Stock compensation to directors in lieu of cash compensation	$ 0.1									0.1
Conversion of shares of class B common stock to class A common stock		$ 0.0									$ 3.8				$ (3.8)
Stock-based compensation expense	3.5									3.5
Net loss	(26.5)											(25.8)		(0.7)
Other comprehensive income	$ (9.2)												(8.9)	(0.3)
Ending balance (in shares) at Mar. 31, 2024	18,750,000		218,735,333	7,326,423	218,735,333		7,326,423
Ending balance at Mar. 31, 2024	$ 1,517.9				$ 0.0		$ 0.0		$ (1.3)	$ 2,063.9		$ (531.2)	$ (74.2)	$ 60.7
Ending balance (in shares) at Mar. 31, 2024	149,076								149,076